Abstract

von Hippel-Lindau syndrome (VHLS) is a rare, autosomal dominant genetic disease with high penetrance and variable phenotypic expression caused by variants in the VHL gene. VHLS is associated with the presence of vascular tumors, often hemangioblastoma of the central nervous system, retina, or spinal cord and, less frequently, pancreatic cystic neoplasm, pancreatic neuroendocrine tumor, clear cell carcinoma of the kidney, endolymphatic sac tumor, pheochromocytoma, and paraganglioma. The authors report a case of a patient with VHLS with a rare pathogenic variant in the VHL gene and with an optic nerve hemangioblastoma, a rare phenotypic expression.Case report: A 49-year-old woman was diagnosed with cystic neoplasm of the pancreas, renal cell carcinoma of the right kidney, and hemangioblastoma of the left optic nerve. The patient's family history revealed siblings with VHLS manifestations. The index case was her mother who died at age 63 of clear cell renal carcinoma. The information was obtained by consulting the patient's medical register and by interviews with the patient and her relatives. The presence of left optic nerve hemangioblastoma was suggested by CT scan of the skull and orbit. The sequencing of the VHL gene was performed in the peripheral blood by the polymerase chain reaction (PCR) technique, and the duplication and deletion research was performed using the multiplex ligation-dependent probe amplification (MPLA) technique. The presence of a rare pathogenic variant c.263G> A (p.Trp88Ter) was observed in heterozygosity in the VHL gene that determined a premature stop codon. CT scan of the skull and orbits suggested the presence of HB in the optic nerve of the left eye. The results of the CT scan of the skull and orbits show thickening with tortuosity of the left optic nerve, with a small area of nodular enhancement. The right optic nerve had a conserved aspect.Conclusion: This is the fourth case described of this rare pathogenic variant of the VHL gene, according to the Human Gene Mutation Database and VHLdb database records and with an optic nerve hemangioblastoma of the optic nerve, a very rare phenotypic expression of the VHLS.

Highlights

  • The von Hippel-Lindau syndrome (VHLS), known as familial cerebello retinal angiomatosis, is an autosomal dominant genetic disease with high penetrance and variable expressivity [1]

  • VHLS is characterized by the presence of benign and/or malignant tumors, most of them of vascular origin, with the most frequent being hemangioblastoma (HB), usually located in the central nervous system (CNS), mainly in the brain and cerebellum [1, 2], and founded in the spinal cord and retina [1]

  • VHLS is determined by the presence of germline or somatic pathogenic variants in the VHL gene, mapped at 3p25.26 [1, 2]

Read more

Summary

Introduction

The von Hippel-Lindau syndrome (VHLS), known as familial cerebello retinal angiomatosis, is an autosomal dominant genetic disease with high penetrance and variable expressivity [1]. The natural history of the disease, including the manifestation of tumors and their severity, is highly variable among affected families, even cases within the same family [1, 2, 5, 6]. The disease is highly penetrating, and 90% of patients develop symptoms before age 65 [1]. An occurrence of genetic anticipation has been observed that determines the involvement of patients at progressively earlier ages and with more severe manifestations in successive generations [2]

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.